Abstract

Animal studies have long been a cornerstone of biomedical and environmental health research, and scientists need assurance that animals used in these studies are being cared for in ways that will not unknowingly influence experimental outcomes. But a growing number of scientists have voiced concern over the possibility that certain estrogenic compounds present in lab animal feed may skew test results. These compounds are deemed potentially problematic because they can bind to estrogen receptors and induce estrogen-like effects in animals, humans, and cells grown in culture. Some experts have advocated strict standardization of rodent chows and even the removal of dietary phytoestrogens. This emergent controversy was the focus of “DIET II—The Effect of Variability in Estrogenic Activity of Commercial Animal Feeds: Interaction with Manufacturers, NIH Officials, and Scientific Societies to Develop a Solution,” a full-day meeting held 3 August 2006 in Research Triangle Park, North Carolina. The meeting, the second in a series on the topic, was cosponsored by the NIEHS and the NIH Office of Dietary Supplements (ODS). Discussions at the meeting centered on the variation in estrogenic activity between feed batches, the effects of these estrogenic components on endocrine-related end points, and the difficulties inherent in comparing, interpreting, and reproducing these end points over time within and between different laboratories when background levels of diet-related estrogenic activity are not adequately documented. Findings presented at this meeting made it clear that researchers studying estrogen-related end points can not afford to overlook the influence of the test rodent’s diet. “This workshop is an excellent example of the cumulative and self-correcting nature of the scientific process,” said ODS nutritionist Elizabeth Yetley, a conference co-organizer. “That is, through the accumulation of results from a body of experimental evidence, the importance of approaches for better-defined animal diets relative to their potential estrogenic activity have been identified, and measures to improve future research in this area are being undertaken by the scientific community.” Participants at the conference—organized by NIEHS scientists Jerrold Heindel and Julius Thigpen, along with Yetley and University of Missouri–Columbia biologist Frederick vom Saal—included investigators from the endocrine disruptor research community as well as representatives from animal feed companies. This spectrum of representatives reflected the fact that, in Heindel’s words, “researchers and animal care divisions of research institutions are beginning to pay attention to the phytoestrogen issue, and feed manufacturers want to know what the scientific community wants.” Heindel described a sincere interest on the part of both sides to reach a “win–win” solution, one that would yield animal diets of a known estrogenicity that could be used by researchers in all fields of physiology and toxicology, but that also would not unduly burden the feed manufacturers.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call